Risk profiles for mild cognitive impairment and progression to dementia are gender specific

Objective: To examine risk factors for mild cognitive impairment (MCI) and progression to dementia in a prospective community-based study of subjects aged 65 years and over. Methods: 6892 participants who were over 65 and without dementia were recruited from a population-based cohort in three French cities. Cognitive performance, clinical diagnosis of dementia, and clinical and environmental risk factors were evaluated at baseline and 2-year and 4-year follow-ups. Results: 42% of the population were classified as having MCI at baseline. After adjustment for confounding with logistic regression models, men and women classified as having MCI were more likely to have depressive symptomatology and to be taking anticholinergic drugs. Men were also more likely to have a higher body mass index, diabetes and stroke, whereas women were more likely to have poor subjective health, to be disabled, to be socially isolated, and to suffer from insomnia. The principal adjusted risk factors for men for progression from MCI to dementia in descending order were ApoE4 allele (OR = 3.2, 95% CI 1.7 to 5.7), stroke (OR = 2.8, 95% CI 1.2 to 6.9), low level of education (OR = 2.3, 95% CI 1.3 to 4.1), loss of Instrumental Activities of Daily Living (IADL) (OR = 2.2, 95% CI 1.1 to 4.5) and age (OR = 1.2, 95% CI 1.1 to 1.2). In women, progression is best predicted by IADL loss (OR = 3.5, 95% CI 2.1 to 5.9), ApoE4 allele (OR = 2.3, 95% CI 1.4 to 4.0), low level of education (OR = 2.2, 95% CI 1.3 to 3.6), subclinical depression (OR = 2.0, 95% CI 1.1 to 3.6), use of anticholinergic drugs (OR = 1.8, 95% CI 1.0 to 3.0) and age (OR = 1.1, 95% CI 1.1 to 1.2). Conclusions: Men and women have different risk profiles for both MCI and progression to dementia. Intervention programmes should focus principally on risk of stroke in men and depressive symptomatology and use of anticholinergic medication in women.

[1]  R. Mayeux,et al.  Implementing diagnostic criteria and estimating frequency of mild cognitive impairment in an urban community. , 2005, Archives of neurology.

[2]  B Isaacs,et al.  The Set Test as an Aid to the Detection of Dementia in Old People , 1973, British Journal of Psychiatry.

[3]  J. Touchon,et al.  Non-degenerative mild cognitive impairment in elderly people and use of anticholinergic drugs: longitudinal cohort study , 2006, BMJ : British Medical Journal.

[4]  J. Morris,et al.  Tangles and plaques in nondemented aging and “preclinical” Alzheimer's disease , 1999, Annals of neurology.

[5]  John Breitner,et al.  Risk factors for mild cognitive impairment in the Cardiovascular Health Study Cognition Study: part 2. , 2003, Archives of neurology.

[6]  E. Tangalos,et al.  Mild Cognitive Impairment Clinical Characterization and Outcome , 1999 .

[7]  H. Soininen,et al.  Incidence and Risk Factors for Mild Cognitive Impairment: A Population-Based Three-Year Follow-Up Study of Cognitively Healthy Elderly Subjects , 2004, Dementia and Geriatric Cognitive Disorders.

[8]  Karen Ritchie,et al.  Classification criteria for mild cognitive impairment: A population-based validation study , 2001 .

[9]  R. Petersen,et al.  Revised Criteria for Mild Cognitive Impairment: Validation within a Longitudinal Population Study , 2006, Dementia and Geriatric Cognitive Disorders.

[10]  O. Spreen,et al.  Predicting premorbid IQ: A revision of the national adult reading test , 1989 .

[11]  I. Loy-English,et al.  Gender differences in dementia risk factors. , 2007, Gender medicine.

[12]  J. Bischkopf,et al.  Mild cognitive impairment 1 : prevalence and predictive validity according to current approaches , 2003, Acta neurologica Scandinavica.

[13]  R. Reitan Validity of the Trail Making Test as an Indicator of Organic Brain Damage , 1958 .

[14]  R. Holman,et al.  Vascular Factors and Risk of Dementia: Design of the Three-City Study and Baseline Characteristics of the Study Population , 2003, Neuroepidemiology.

[15]  W. Krampla,et al.  Conversion from subtypes of mild cognitive impairment to Alzheimer dementia , 2007, Neurology.

[16]  Kenneth Rockwood,et al.  Variations in case definition affect prevalence but not outcomes of mild cognitive impairment , 2003, Neurology.

[17]  Charles DeCarli,et al.  Sex, apolipoprotein E epsilon 4 status, and hippocampal volume in mild cognitive impairment. , 2005, Archives of neurology.

[18]  B. Dubois,et al.  ["The 5 words": a simple and sensitive test for the diagnosis of Alzheimer's disease]. , 2002, Presse medicale.

[19]  L. Fratiglioni,et al.  Psychiatric symptoms/syndromes in elderly persons with mild cognitive impairment. Data from a cross‐sectional study , 2003, Acta neurologica Scandinavica. Supplementum.

[20]  D. Knopman,et al.  Incident dementia in women is preceded by weight loss by at least a decade , 2007, Neurology.

[21]  K. Ritchie Mild cognitive impairment: an epidemiological perspective , 2004, Dialogues in clinical neuroscience.

[22]  C. Jack,et al.  Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment , 2004, Journal of internal medicine.

[23]  G. Dunbar,et al.  The validity of the Mini International Neuropsychiatric Interview (MINI) according to the SCID-P and its reliability , 1997, European Psychiatry.

[24]  Charles DeCarli,et al.  Sex, Apolipoprotein E ε4 Status, and Hippocampal Volume in Mild Cognitive Impairment , 2005 .

[25]  M P Lawton,et al.  Scales to measure competence in everyday activities. , 1988, Psychopharmacology bulletin.

[26]  G. Dunbar,et al.  The Mini International Neuropsychiatric Interview (MINI). A short diagnostic structured interview: reliability and validity according to the CIDI , 1997, European Psychiatry.

[27]  C. Jack,et al.  Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment , 1999, Neurology.